Abstract:Funding Acknowledgements Type of funding sources: Other. Main funding source(s): HARP Wellcome Trust PhD Fellowship Grant & NIHR Biomedical Research Centre Introduction Coronary artery disease (CAD) remains the number one cause of death in women worldwide despite advances in treatment (1). Women who experience myocardial infarction (MI) and undergo invasive angiography experience higher morbidity and mortality compared to their male counterparts. Data suggests that this mortality difference may be predominantly in women >55 years (2). Treatment bias may be an important factor. Prognostic benefit of optimal medical therapy (OMT) following MI is well established, however studies and meta-analyses suggest women may be less likely to receive this compared to men e.g (3, 4). Purpose We aimed to establish whether there were sex differences in OMT received following invasive angiography for obstructive CAD at a large cardiac centre. Methods In this single centre retrospective study, we examined OMT received by females and males undergoing invasive angiography in 2019 with proven obstructive CAD, as defined by an angiographic lesion ≥50% of luminal diameter. Discharge medications were extracted from the electronic patient record and entered into a database. Pooled analysis of sex differences and sub-group analysis according to diagnosis (STEMI, NSTEMI, stable angina) and age (≤ 55 years or >55 years) was performed. Multivariate binomial logistic regression was used to adjust for confounders including BMI, diabetes, hypertension, hypercholesterolaemia, previous MI and previous percutaneous coronary intervention. Results 4,346 patients underwent invasive angiography during the study period. 2,358 with obstructive CAD and full medication details available at the present time were included (STEMI: 649 [mean age: 59.7, 20.6 % female], NSTEMI: 439 [mean age 63.4, 22.6% female], Stable angina: 1,270 [mean age 63.7, 22.2% female]). Pooled analysis showed females were less likely to receive aspirin and beta-blockers (OR=0.64, p=0.009, OR=0.66, p=0.001). They also received fewer angiotensin-converting enzyme inhibitors (ACE-I) but more angiotensin receptor blockers (ARB) (OR=0.58, p 55 with STEMI were less likely to receive beta-blockers and high potency antiplatelets compared to males (OR=0.49, p=0.009, OR=0.44, p=0.011). In the NSTEMI group females ≤55 received fewer beta-blockers and statins (OR=0.16, p=0.020, OR=0.004, p=0.045). In the stable angina group females ≤55 were less likely to receive aspirin (OR=0.07, p<0.001). Fewer ACE-I and more ARB in females was predominantly in the stable angina group (OR=0.56, p<0.001, OR= 1.50, p=0.021). Conclusion Women undergoing invasive angiography for obstructive CAD appeared to receive less OMT compared to men across several drug categories, diagnoses and age groups. Future work will be directed at understanding why these differences occurred and the mechanistic consequences of these differences in OMT pharmacology between females and males.

What problem does this paper attempt to address?

This paper aims to address the differences in optimal medical therapy (OMT) between men and women after invasive angiography in patients with coronary artery disease (CAD). Specifically, the study focuses on whether women are less likely to receive the recommended optimal medical therapy than men, and whether this difference is related to factors such as the patient's age, diagnosis type (STEMI, NSTEMI, stable angina). ### Research Background Coronary artery disease (CAD) remains the leading cause of death among women worldwide, despite advances in treatment methods. After experiencing myocardial infarction (MI) and undergoing invasive angiography, women have a higher morbidity and mortality rate than men, especially women over 55 years old. Research data indicate that this mortality difference may mainly occur in women over 55 years old. In addition, treatment bias may be an important factor contributing to this phenomenon. Although the prognostic benefits of optimal medical therapy (OMT) for patients after myocardial infarction have been widely recognized, studies have shown that women may be less likely to receive these treatments than men. ### Research Objectives The objective of this study is to determine whether there are gender differences in optimal medical therapy for obstructive coronary artery disease after invasive angiography in men and women in a large - scale cardiac center. ### Research Methods This is a single - center retrospective study. The researchers analyzed patients who underwent invasive angiography in 2019 and were diagnosed with obstructive coronary artery disease (defined as vascular stenosis ≥ 50%). Drug information at discharge was extracted from electronic medical records and entered into a database. The study conducted a summary analysis of gender differences and subgroup analyses according to diagnosis (STEMI, NSTEMI, stable angina) and age (≤ 55 years or > 55 years). Multivariate binomial logistic regression was used to adjust for confounding factors, including BMI, diabetes, hypertension, hypercholesterolemia, previous myocardial infarction, and previous percutaneous coronary intervention. ### Main Findings - **Overall Results**: Female patients were less likely to receive aspirin and β - blockers (OR = 0.64, \(p = 0.009\); OR = 0.66, \(p = 0.001\)). Women were also less likely to receive angiotensin - converting enzyme inhibitors (ACE - I), but more likely to receive angiotensin receptor blockers (ARB) (OR = 0.58, \(p < 0.001\); OR = 1.45, \(p = 0.009\)). - **Subgroup Analyses**: - **STEMI Patients**: Women over 55 years old were less likely to receive β - blockers and high - efficiency anti - platelet drugs (OR = 0.49, \(p = 0.009\); OR = 0.44, \(p = 0.011\)). - **NSTEMI Patients**: Women under 55 years old were less likely to receive β - blockers and statins (OR = 0.16, \(p = 0.020\); OR = 0.004, \(p = 0.045\)). - **Stable Angina Patients**: Women under 55 years old were less likely to receive aspirin (OR = 0.07, \(p < 0.001\)). Women over 55 years old were less likely to receive ACE - I, but more likely to receive ARB (OR = 0.56, \(p < 0.001\); OR = 1.50, \(p = 0.021\)). ### Conclusions In terms of optimal medical therapy after invasive angiography, women show deficiencies compared to men in multiple drug categories, diagnosis types, and age groups. Future research will focus on understanding the reasons for these differences and their pharmacological mechanism consequences between women and men in OMT. Through this study, the authors hope to reveal the impact of gender differences in the treatment of coronary artery disease, thereby promoting more equitable and effective medical practices.

Sex differences in optimal medical therapy following invasive angiography for coronary artery disease